The Effect of Lipid-Lowering Therapy on Coronary Artery Plaque in East Asia Population
LLT is beneficial for East Asian patients with established ASCVD or with higher risks of ASCVD. Intensive LLT with a lower target LDL-C, especially to <55 mg/dL, would be beneficial for atherosclerosis treatment.
Authors
- Tomohiro Fujisaki (ORCID: https://orcid.org/0000-0001-9204-8551)
- Nobuhiro Osada (ORCID: https://orcid.org/0009-0005-5422-6456)
- Kenichi Tsujita (ORCID: https://orcid.org/0000-0002-4314-259X)
- Ken Ikeda (ORCID: https://orcid.org/0000-0002-1655-5874)
- Yuichiro Shirahama (ORCID: https://orcid.org/0000-0002-4101-8667)
- Satoru Tanaka (ORCID: https://orcid.org/0000-0003-3370-0188)
- Zhifeng Sheng (ORCID: https://orcid.org/0000-0003-2308-3024)
- Yang Zhang (ORCID: https://orcid.org/0000-0002-2367-2761)
Institutions
- National Cerebral and Cardiovascular Center (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- JACC Asia
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1016/j.jacasi.2025.05.016
- Citations
- 7
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 14.04